| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.008 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.008 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |